. Here we explore the importance within the biotechnology industry of the non-financial metrics firms used to convey value … was a change over time in the importance of various metrics in determining the value of a biotechnology firm. We find that … value. Our results also suggest that the biotechnology regime changed and the Nobel Prize lost its luster as a signal of …

operate as well as concentration in the agricultural biotechnology industry also emerged due to intellectual property rights …

breakthroughs (e.g., biotechnology, lasers, semiconductors, nanotechnology). Unless congruent with incumbents' science and …

In this paper, we examine the determinants of control rights in technology strategic alliances between biotechnology … firms and pharmaceutical corporations, as well as with other biotechnology firms. We undertake three clinical studies and an …

Using detailed data on biotechnology in Japan, we find that identifiable collaborations" between particular university …

profound, biotechnology applications in this large incumbent firm are more likely to be combined with other techno- logies than … in the new biotechnology firms (NBFs) which use biotechnology for both discovery and production of new therapeutic … more effective applications of the new technologies, but it could retard full adoption of biotechnology. It appears that …